← Open Payments lookup

NPI 1801187489: Open Payments

NPI 1801187489. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$409 in 20 payments from 10 companies in 2025. Trend: 2023 $523 · 2024 $430 · 2025 $409

Food & beverage: $409
CompanyPaymentsAmount
Novo Nordisk Inc6$149
AstraZeneca Pharmaceuticals LP3$48
Lilly USA, LLC2$42
Abbott Laboratories2$41
ABBVIE INC.2$37
Axsome Therapeutics, Inc.1$21
Exact Sciences Corporation1$20
Takeda Pharmaceuticals U.S.A., Inc.1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
Phathom Pharmaceuticals, Inc.1$15

Products named: Wegovy, Ozempic, AIRSUPRA, JARDIANCE, Rybelsus, UBRELVY, Auvelity, Cologuard Collection Kit.